PARKWAYLIFE REIT (SGX:C2PU)
Parkway Life REIT - Comprehensive Strategic Collaboration That Surpasses Our Expectations
- Parkway Life REIT (SGX:C2PU)’s strategic collaboration with sponsor IHH Healthcare (SGX:Q0F) is comprehensive, encompassing the extension of master leases, renewal capex and ROFR to acquire Mount Elizabeth Novena Hospital. Cumulatively, total rental growth is 39.4% in Year 4 of the new 20-year lease term and exceeds our expectations.
- The package is accretive to Parkway Life REIT's DPU by 32% and NAV per share by 26% in 2026 (Year4).
- Parkway Life REIT's share price performance has been spectacular, gaining 23.3% year-to-date. Downgrade to HOLD.
Parkway Life REIT has extended its strategic collaboration with sponsor IHH Healthcare
Extension for 20 years with sizeable step-up in rents.
- Parkway Life REIT (SGX:C2PU) has entered into a lease framework agreement for the extension of master leases of its three Singapore hospitals, namely Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. The initial rent for 2023 is S$97.2m, supported by rental valuations conducted by CBRE and Knight Frank.
- Cumulatively, total rental growth is 39.4% for Year 4 of the 20-year lease term. Rental escalation is set at CPI + 1% from Year 4 to Year 20.
- Parkway Life REIT's WALE has increased from 5.7 years to 16.6 years. There is also an option to renew for a further 10 years (2043 to 2052).
Renewal that enhances capital values.
- Parkway Life REIT will invest in Jan 23. Parkway Life REIT will grant a total rental rebate of S$60.9m during 2023 to 2025.
Potential injection of Mount Elizabeth Novena Hospital.
- Parkway Life REIT is granted the right EGM to be convened in due course.
STOCK IMPACT
Win-win outcome facilitates future collaborations.
- The successful completion of the extension would pave the way for future collaborations between Parkway Life REIT and its sponsor IHH Healthcare. They could involve:
- Parkway Life REIT acquiring Mount Elizabeth Novena Hospital, and
- partnership in overseas expansion whereby IHH Healthcare acquires the healthcare operators while Parkway Life REIT acquires the healthcare assets.
Strong positive impact on DPU and NAV per unit.
- On a pro forma basis, management estimates positive unit is estimated to increase by 19.9% to S$2.35 in Year 1 and a further 6% to S$2.49 in Year 4.
EARNINGS REVISION
- We forecast Parkway Life REIT to provide
- DPU of S$0.152 for 2023 (Year1),
- DPU of S$0.154 for 2024 (Year2),
- DPU of S$0.157 for 2025 (Year3) and
- DPU of S$0.187 for 2026 (Year4).
VALUATION & RECOMMENDATION
- Downgrade Parkway Life REIT to HOLD.
- Parkway Life REIT’s strategic collaboration is on a year-to-date basis.
- See
- Our new target price is based on DDM (cost of equity: 5.5%, terminal growth: 2.0%).
SHARE PRICE CATALYST
- Extension of leases for Singapore hospitals.
- Yield-accretive acquisitions.
Jonathan KOH CFA
UOB Kay Hian Research
|
https://research.uobkayhian.com/
2021-07-15
SGX Stock
Analyst Report
4.72
UP
4.380